PharmTech LCGC Sciex Webinar 11.10
|Webcasts|June 1, 2017

A Risk-Based Approach to Reviewing Electronic Chromatographic Data and Audit Trails with Data Integrity in Mind

There is a struggle to adequately “document” audit trail review, which leads to the wider concern-how to adequately document any kind of quality review. What exactly does “signing a document” indicate? On Demand available until Jun. 1, 2018 Register Free: http://www.chromatographyonline.com/lcgc_w/data

Register Free: http://www.chromatographyonline.com/lcgc_w/data

Since Annex 11 first raised in regulation the need for audit trail review, there has been much discussion in industry about how to ensure that information contained in electronic audit trails is reviewed along with the actual data and other meta data.

Amongst the plethora of data integrity guidances issued by regulatory authorities, there appears to be a mixture of expectations, including some truly non risk-based approaches indicating a need for 100% review. In many companies audit trail review always formed a part of any data review SOP.  Some companies have since attempted to create a separate audit trail review SOP, without much thought to the quality and value this exercise adds. Additionally there is a struggle to adequately “document” audit trail review, which leads to the wider concern-how to adequately document any kind of quality review. What exactly does “signing a document” indicate?

 

Speaker: Heather Longden, Senior Marketing Manager, Informatics and Regulatory Compliance, Waters Corporation 

 

Date and Time: 

Live: Thursday, 1 June, 2017 | 10 am EDT | 9 am CDT | 1500 BST | 1600 CEST 

After the final airing of the webcast 1 June, 2017 it will be available on demand until 1 June, 2018. 

Sponsor: Waters Corporation 

Register Free: http://www.chromatographyonline.com/lcgc_w/data


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.